MedPath

HONG KONG WD PHARMACEUTICAL CO., LIMITED

🇭🇰Hong Kong, China
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

5

Active:0
Completed:1

Trial Phases

1 Phases

Phase 1:5

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (5 trials with phase data)• Click on a phase to view related trials

Phase 1
5 (100.0%)

PK Study of WD-1603 in Healthy Subjects

Phase 1
Conditions
Parkinson Disease
Interventions
Drug: WD-1603 CARBIDOPA/LEVODOPA EXTENDED-RELEASE TABLETS
First Posted Date
2020-10-19
Last Posted Date
2020-10-19
Lead Sponsor
Hong Kong WD Pharmaceutical Co., Limited
Target Recruit Count
8
Registration Number
NCT04591535
Locations
🇮🇳

Lambda Therapeutic Research Ltd., Ahmedabad, India

A Single Dose Bioequivalence Study of WD-1602 Versus Pradaxa® in Healthy Subjects Under Fed Condition

Phase 1
Conditions
Anticoagulant
Interventions
First Posted Date
2020-10-19
Last Posted Date
2020-11-02
Lead Sponsor
Hong Kong WD Pharmaceutical Co., Limited
Target Recruit Count
20
Registration Number
NCT04592822

A Single Oral Dose, Crossover Comparative PK Study of WD-1603 in Healthy Subjects Under Fasting Conditions

Phase 1
Conditions
Parkinson Disease
Interventions
First Posted Date
2020-09-18
Last Posted Date
2020-09-22
Lead Sponsor
Hong Kong WD Pharmaceutical Co., Limited
Target Recruit Count
8
Registration Number
NCT04553978

WD-1603 PK Study Under Fasting and Fed Conditions in Healthy Subjects

Phase 1
Conditions
Parkinson Disease
Interventions
Drug: WD-1603 CARBIDOPA and LEVODOPA EXTENDED-RELEASE TABLETS
First Posted Date
2020-08-14
Last Posted Date
2020-09-10
Lead Sponsor
Hong Kong WD Pharmaceutical Co., Limited
Target Recruit Count
8
Registration Number
NCT04513340
Locations
🇮🇳

Lambda Therapeutic Research Ltd., Ahmedabad, India

WD-1603 PK Study in Healthy Volunteers

Phase 1
Completed
Conditions
Healthy Volunteers
Interventions
Drug: carbidopa-levodopa
First Posted Date
2018-12-03
Last Posted Date
2020-02-13
Lead Sponsor
Hong Kong WD Pharmaceutical Co., Limited
Target Recruit Count
8
Registration Number
NCT03761004
Locations
🇨🇦

INC Research Toronto, Inc., Toronto, Canada

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.